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Dyrk is a dual specific protein kinase thought to be
involved in normal embryo neurogenesis and brain de-
velopment. Defects/imperfections in this kinase have
been suggested to play an important role in the mental
retardation of patients with Down’s syndrome. The tran-
scriptional factor cAMP response element-binding pro-
tein (CREB) has been implicated in the formation of
many types of synaptic plasticity, such as learning and
memory. In the present study we show that Dyrk1 activ-
ity is markedly induced during the differentiation of
immortalized hippocampal progenitor (H19-7) cells. The
addition of a neurogenic factor, basic fibroblast growth
factor, to the H19-7 cells results in an increased specific
binding of Dyrk1 to active CREB. In addition, Dyrk1
directly phosphorylates CREB, leading to the stimula-
tion of subsequent CRE-mediated gene transcription
during the neuronal differentiation in H19-7 cells.
Blockade of Dyrk1 activation significantly inhibits the
neurite outgrowth as well as CREB phosphorylation in-
duced by basic fibroblast growth factor. These findings
suggest that Dyrk1 activation and subsequent CREB
phosphorylation is important in the neuronal differen-
tiation of central nervous system hippocampal cells.
The regulation of gene expression by specific signal trans-
duction pathways is tightly connected to the cell phenotype.
The response elicited by a given transduction pathway varies
according to the cell type. One major signal transduction sys-
tem utilizes cAMP as a secondary messenger and has as its
ultimate target a DNA control element, the cAMP response
element (CRE)1 (1). The CRE-binding protein (CREB) is a
transcription factor that activates CRE-mediated transcrip-
tion. CREB activity is regulated by multiple kinases after var-
ious kinds of stimulation (2). Specific roles for CREB in neuro-
nal development and differentiation have been revealed
through in vivo and in vitro manipulations of CREB function.
For example, the expression of a dominant-interfering CREB
within certain pituitary neurons causes them to develop abnor-
mally and die perinatally (3).
“Minibrain” (Mnb) is a mutant of Drosophila whose presence
is exhibited by a specific and marked size reduction of the optic
lobes and central hemispheres in the adult brain (4). The Mnb
gene encodes a Ser/Thr protein kinase that possesses a Tyr-X-
Tyr sequence in the activation loop (5). At least 7 closely related
homologous mammalian kinases have since been isolated, and
a novel superfamily of protein kinases called Dyrk(s) has been
established (6). Dyrks possess Ser/Thr phosphorylation activity
as well as autophosphorylation activity on Tyr residues, sug-
gesting that Dyrk seems to be a dual specificity kinase (5, 6).
The kinase activity of Dyrk is dependent on the Tyr-X-Tyr
motif in the activation loop, suggesting the existence of a phos-
phorylation-dependent activation mechanism of Dyrk by cer-
tain upstream kinases (6). The most homologous protein among
the Dyrks in the Saccharomyces cerevisiae genome is YAK1,
which has been characterized as a negative regulator of growth
(7). Interestingly, human Dyrk1A is mapped to the Down’s
syndrome (DS) critical region on chromosome 21 (4-megabase
region containing 60100 genes between the markers D21S17
and ETS2) (31) and, thus, could be a candidate gene responsi-
ble for the mental retardation of DS patients (8). Thus, from
Drosophila to humans, it is suggested that Dyrk/Mnb is a key
regulator of neuronal cell growth (36). Although the exact cel-
lular function of the Dyrk kinases is still unknown, an under-
standing of the physiological role(s) of this protein kinase fam-
ily will prove to be very relevant.
Although little is known about the mechanism by which the
overexpression of Dyrks interferes with normal development in
DS patients, Dyrk genes are strongly implicated in normal
neuronal development by a mechanism that may involve a
signal transduction pathway (36). This study examined the
functional role played by Dyrk1 during the neuronal differen-
tiation in hippocampal progenitor cells. We found that Dyrk1 is
activated and phosphorylates the transcription factor CREB
during neuronal differentiation. In addition, Dyrk1 activation
induces CRE-mediated gene transcription. These findings sug-
gest that Dyrk1 may play an important role during neurogenic
factor-induced differentiation of central nervous system (CNS)
neuronal cells.
EXPERIMENTAL SECTION
Materials—The following materials were purchased. Peroxidase-con-
jugated anti-rabbit and anti-mouse immunoglobulins (IgGs) were from
Zymed Laboratories Inc. (San Francisco, CA); Dulbecco’s modified Ea-
gle’s medium, fetal bovine serum, and cell culture reagents were from
Life Technologies, Inc.; protein A-Sepharose was from Amersham Phar-
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DS, Down’s syndrome; ECL, enhanced chemiluminescence; GST, glu-
tathione S-transferase; HA, hemagglutinin; Mnb, minibrain; TK, thy-
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ered saline with Tween; EGF, epidermal growth factor; PAGE,
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macia Biotech; enhanced chemiluminescence (ECL) reagents and
[-32P]ATP were from PerkinElmer Life Sciences; anti-Dyrk IgG was
from Becton Dickinson; anti-CREB IgG was from NEN Cell Signaling
(Beverly, MA); anti-phosphorylated CREB antibodies were from Up-
state Biotechnology (Lake Placid, NY); synthetic dropout medium (SD/
T, SD/L, SD/HLT) and yeast extract peptone dextrose containing
adenine were from Bio101 (Vista, CA); 3-amino-1,2,4-triazole was from
Sigma; 5-bromo-4-chloro-3-indoryl-D-galactoside and luciferase assay
kit were from Promega (Madison, WI); human fetal brain cDNA library
was from CLONTECH (Palo Alto, Calif.); human basic FGF was from
Bachem (Bubendorf, Switzerland). As gifts, pCRE-TK-Luc and pTK-
Luc constructs were received from K. Saeki (Research Institute, Inter-
national Medical Center of Japan). The plasmids encoding hemagglu-
tinin (HA)-tagged pSVL-HA-Dyrk1A and mutant type K188R were
provided by W. Becker (Institute of Pharmacology and Toxicology,
RWTH, Aachen, Germany).
Yeast Two-hybrid Assay—The bait vector for yeast two-hy-
brid assay was constructed by subcloning the mutant CREB
cDNA, in which RRPSY (amino acid 130–134) was replaced by
RRSLY, into pHybTrp/Zeo vector. Human fetal cDNA library
subcloned into prey vector (pACT2) was purchased from
CLONTECH. The yeast strain L40, containing the reporter
genes lacZ and HIS3 downstream of the LexA promoter, was
sequentially transformed with bait vector followed by cDNA
library vectors and then plated on a synthetic medium contain-
ing 5 mM 3-amino-1,2,4-triazole and lacking histidine, leucine,
and tryptophan residue. After incubating the plates for 10–14
days at 30 °C, the transformants were tested with a synthetic
medium lacking histidine, leucine, and tryptophan residue and
containing 50 g/ml 5-bromo-4-chloro-3-indoryl-D-galactoside.
After incubation for 2–3 days at 30 °C, the yeast colonies show-
ing blue color were selected as positive clones. The positive
clone plasmids were extracted from yeast in lysis buffer con-
taining 2% Triton X-100, 1% SDS, 100 mM NaCl, 10 mM Tris,
pH 8.0, and 1.0 mM EDTA and then transformed into Esche-
richia coli DH5 using electroporation. Sequences of the in-
serts in positive library plasmids were analyzed by automatic
DNA sequencer (ALF express, Amersham Pharmacia Biotech).
Cell Culture and Preparation of Cell Lysates—H19-7 cells
were generated from rat embryonic hippocampal neurons (9).
They were conditionally immortalized by stable transfection
with temperature-sensitive SV40 large T antigen. They were
grown in Dulbecco’s modified Eagle’s medium containing 10%
fetal bovine serum and 100 units/ml penicillin-streptomycin
under G418 selection throughout the experiments. To induce
neuronal differentiation, the cells were placed in N2 medium
and shifted to 39 °C before treatment with differentiating
agents as previously described (10). To test the effect of Dyrk1
activation on the neuronal differentiation in H19-7 cells, the
cells were transfected with a plasmid encoding either wild type
or kinase-inactive Dyrk1 at 33 °C for 24 h. Then the cells were
switched to N2 medium, cultured at 39 °C for 48 h, treated with
bFGF, and analyzed for morphological changes with a optical
microscope (Zeiss, Thornwood, NY). Differentiated cells were
defined as cells with a rounded and refractory cell body con-
taining at least one neurite whose length was greater than the
cell body diameter. To prepare cell lysates, the cells were rinsed
twice with ice-cold phosphate-buffered saline and solubilized in
lysis buffer (20 mM Tris, pH 7.9, containing 1.0% Triton X-100,
1 mM Na3VO4, 137 mM NaCl, 1 g/ml leupeptin, 1 g/ml apro-
tinin, 1 mM sodium orthovanadate, 1 mM EGTA, 10 mM NaF, 1
mM tetrasodium pyrophosphate, 5 mM Na2EDTA, 10% glycerol,
1 mM -glycerophosphate, 0.1 g/ml p-nitrophenylphosphate,
and 0.2 mM phenylmethylsulfonyl fluoride). The cells were
scraped, and the supernatants were collected after centrifuga-
tion for 10 min at 14,000  g at 4 °C. Protein concentrations
were determined using the Bio-Rad detergent-compatible pro-
tein assay kit.
DNA Transfection and Luciferase Reporter Assay—The
H19-7 cells were plated at a density of 2  106 cells per well in
100-mm-diameter dishes. When the cell confluency was
7090%, the cells were transfected with suitable plasmid con-
structs using LipofectAMINE Plus reagent (Life Technologies)
according to the manufacturer’s instruction. Where indicated,
luciferase reporter construct, pCRE-TK-Luc, was transiently
co-transfected with kinase-inactive Dyrk1 mutant (K188R),
and the luciferase activity was measured using a luciferase
assay kit (Promega) and a luminometer (EG & G Berhold,
Germany). In every transfection experiment the CRE-lacking
thymidine kinase (TK) promoter construct (pTK-Luc) was used
as a negative control.
Immunoprecipitation—One microgram of either monoclonal
anti-Dyrk1 or polyclonal anti-CREB antibodies was incubated
at 4 °C overnight with 300 g of cell extracts prepared using
lysis buffer. Forty microliter of a 1:1 suspension of protein
A-Sepharose beads was added to the cell lysates and incubated
for 2 h at 4 °C with gentle rotation. The beads were pelleted
and washed extensively with cell lysis buffer. Bound proteins
were dissociated by boiling the samples in PAGE sample
buffer, and whole samples were separated on SDS-PAGE gel.
Western Blot Analysis—The whole cell lysates were separated
through a 10% SDS-PAGE gel and transferred to a polyvinyli-
dene difluoride membrane (Millipore, Japan). The membranes
were blocked in TBST (20 mM Tris, pH 7.6, 137 mM NaCl, and
0.05% Tween 20) containing 3% nonfat dry milk for 3 h and then
incubated overnight at 4 °C in 3% nonfat dry milk containing
either anti-phospho CREB, anti-CREB, or anti-Dyrk1 (Becton
Dickinson). The membrane was then washed several times in
TBST and incubated with anti-mouse IgG-coupled horseradish
peroxidase antibodies. After 1 h, the blot was washed several
times with TBST and developed with ECL reagents.
In Vitro Dyrk Assay—H19-7 cells were grown in Dulbecco’s
modified Eagle’s medium containing 10% fetal bovine serum
and switched to N2 medium before differentiation for 2 days at
39 °C. The cells were treated with 10 ng/ml of bFGF, harvested,
and lysed in lysis buffer. Then 300 g of protein was incubated
with monoclonal Dyrk1 antibody overnight at 4 °C. The im-
muno-complexes were added to 40 l of protein A-Sepharose
beads. After incubation, the samples were washed three times
in lysis buffer, and the kinase reactions were carried out at
30 °C for 1 h in 20 l of kinase buffer containing 20 mM HEPES,
pH 7.2, 5 mM MnCl2, 200 M sodium orthovanadate, 5 g of
acid-treated enolase, 10 M ATP, 5 Ci of [-32P]ATP, and 5 g
of either bacterially expressed glutathione S-transferase
(GST)-CREB or mutant GST-CREB (S133A) as a substrate.
The reactions were stopped by adding SDS-PAGE sample
buffer and analyzed by SDS-PAGE followed by autoradiograpy.
RESULTS
Yeast Two Hybrid Assay to Identify Novel CREB Kinase(s)
Activated during Neuronal Differentiation—Immortalized hip-
pocampal H19-7 cells differentiate in response to bFGF at
39 °C, the temperature at which the simian virus 40 large T
antigen is not active (11). In an earlier work we have shown
that CREB phosphorylation and subsequent CRE-mediated
gene transcription play an important role during bFGF-in-
duced neuronal differentiation in H19-7 cells and that the
activation of novel protein kinase-signaling pathways is re-
quired for bFGF-responsiveness (12). During the differentia-
tion of H19-7 cells, Ser-133 residue in the CREB protein was
phosphorylated rapidly and sustained for 1–2 h after growth
factor stimulation. In addition, the activation of two previously
unreported CREB kinases in response to bFGF was observed
by using in vitro in-gel kinase assays (12). In the present study,
in order to isolate the novel CREB kinase(s) we undertook
yeast two-hybrid assays by using mutant CREB mutant in
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which the critically regulatory Pro-132–Ser-133 residues of
CREB had been mutated to Ser-132–Leu-133 as bait. As a
result of the screening of human fetal brain cDNA library, we
identified a number of unknown as well as previously reported
CREB-interacting genes, for example, histone deacetylase (34),
retinoblatoma-binding protein 4 (35), and zinc finger protein
ZEB. A BLAST search revealed that one of the isolated clones
encodes a partial clone of mammalian homolog of yeast mini-
brain kinase, Dyrk1. Because Dyrk1 was known to be impor-
tant in the cell cycle control in neuronal cells and implicated in
the pathogenesis of DS mental retardation, we chose Dyrk1 as
a target for further analysis.
Specific Binding between CREB and Dyrk1 during the Neu-
ronal Differentiation in H19-7 Cells—Next we examined
whether Dyrk1 specifically binds to CREB in mammalian neu-
ronal cells and how the neurogenic growth factor affects the
expression of Dyrk1 during neuronal differentiation. The
H19-7 cell extracts obtained after the stimulation with neuro-
genic bFGF were immunoprecipitated against anti-Dyrk1 an-
tibodies and then blotted with anti-phospho-CREB antibodies.
As shown in Fig. 1A, the expression of Dyrk1 protein with 105
kDa was not induced by bFGF, whereas significant levels were
constitutively expressed in H19-7 cells. Although there was no
complex formation without any stimulation, the addition of
bFGF led to an increase of Dyrk1 binding to phosphorylated
CREB. In the following experiment, the cells were either not
transfected (Fig. 1C) or transiently transfected with a plasmid
encoding HA-tagged wild type Dyrk1 (Fig. 1B). Then the cells
were stimulated with bFGF under differentiating conditions,
the cell lysates were immunoprecipitated against either anti-
CREB or anti-phospho-CREB antibodies, and the protein mix-
tures were analyzed using anti-HA tag (Fig. 1B) or anti-Dyrk1
IgG (Fig. 1C). Consistent with the previous finding, bFGF
stimulation promoted the formation of binding complex be-
tween Dyrk1 and phospho-CREB in H19-7 cells. A construct
encoding dominant-negative Dyrk1 was used to block the acti-
vation of Dyrk1. When the kinase-inactive K188R Dyrk1
(pSVL-HA-Dyrk1A/K188R), in which critical Lys-188 residue
in the catalytic domain of Dyrk1 was converted to Arg-188 (13),
was transiently transfected into the cells, the specific binding
of Dyrk1 to active CREB markedly decreased in response to
bFGF (Fig. 1, A–C). As a control for protein loading, we meas-
ured the amount of immunoprecipitated CREB by Western blot
analysis. In all samples, CREBs were present at the same
levels (Fig. 1B). These results indicate that Dyrk1 specifically
binds to active CREB in response to neurogenic growth factor.
Dyrk1 Is Selectively Activated by bFGF, but Not by EGF, in
H19-7 Cells—Because Dyrk1 is activated by tyrosine phospho-
rylation in the activation loop of the catalytic domain (14), we
examined whether Dyrk1 is also activated by bFGF. After cells
were stimulated with bFGF, the cell lysates were immunopre-
cipitated against anti-Dyrk1 antibodies, and the precipitated
Dyrk1-bound mixtures were analyzed using anti-phosphoty-
rosine antibodies. As shown in Fig. 2, the tyrosine phosphoryl-
ation of Dyrk1 increased in response to bFGF. Compared with
the control cells, the overexpression of kinase-dead Dyrk1 mu-
tants by transient transfection extensively repressed the Dyrk1
phosphorylation, suggesting that the addition of bFGF induces
Dyrk1 activation. Differences in CREB phosphorylation are
known to be critical in the determination and regulation of both
mitogenic factor-mediated proliferation and neurotrophin-me-
diated differentiation in neuronal PC12 cells (15). Like PC12
cells, H19-7 cells also respond differentially to EGF and bFGF
(12). At the permissive temperature (33 °C) EGF treatment
induces proliferation, whereas at the nonpermissive tempera-
ture (39 °C), the addition of either FGF or phorbol 12,13-dibu-
tyrate, but not EGF, induces differentiation (9, 16). Further-
more, in contrast to prolonged CREB phosphorylation by
neurogenic bFGF, the addition of EGF induces transient CREB
phosphorylation. These findings from previous studies imply
that stable CREB activation by bFGF is important in deciding
the fate of hippocampal progenitor cell to terminally differen-
tiate to neuronal cell (12). To determine whether Dyrk1 acti-
vation is selectively induced during neuronal differentiation in
H19-7 cells, the cells were stimulated with either EGF under
mitogenic conditions or bFGF under differentiation conditions.
Then immunoprecipitation was performed with the cell lysates
using anti-Dyrk1 antibodies followed by Western blot analysis
against an antibody specific for phosphotyrosine residue to
detect Dyrk1 activation. Compared with a stable but slight
activation of Dyrk1 within 2 h after EGF stimulation (Fig. 3A),
a transient but significant phosphorylation of Dyrk1 was ob-
served upon the stimulation with bFGF reaching the maximum
FIG. 1. Dyrk1 interacts with active CREB in hippocampal
H19-7 cells. Where indicated, H19-7 cells were transfected with 5 g of
a plasmid encoding either HA-tagged wild type or kinase-deficient
Dyrk1 for 24 h. The cells were then stimulated with 10 ng/ml bFGF for
1 h under differentiation conditions. Total cell lysates were immuno-
precipitated with either monoclonal anti-Dyrk 1 IgG followed by blot-
ting with polyclonal anti-Dyrk1 or anti-phospho-CREB antibodies (A) or
anti- CREB followed by the blotting with anti-HA or anti-Dyrk1 anti-
bodies (B). In panel C, the cell lysates were immunoprecipitated with
anti-phospho-CREB and blotted with anti-Dyrk1 antibodies. All ex-
pressed results are representative of three independent experiments.
IP, immunoprecipitation; WT, wild Dyrk1 type; MT, kinase-inactive
Dyrk1 mutant; No T, no treatment; Cont, control.
FIG. 2. Basic FGF-induced tyrosine phosphorylation of Dyrk1
in H19-7 cells. Where indicated, the cells were treated with vehicle or
transiently transfected with 5 g of plasmid encoding kinase-inactive
Dyrk1 (K118R). The cells were treated with 10 ng/ml bFGF under
differentiating conditions for 1 h. Total cell lysates were immunopre-
cipitated with monoclonal anti-Dyrk1 IgG, and bound proteins were
resolved onto SDS-PAGE and detected with an anti-phospho-Tyr (pTyr)
antibody. All expressed results are representative of three independent
experiments. IP, immunoprecipitation; MT, Dyrk1 K118R mutant;
Cont, control; No T, no treatment.
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peak at 1 h (Fig. 3B). In addition, the addition of either EGF at
39 °C or bFGF at 33 °C failed to induce a significant tyrosine
phosphorylation of Dyrk (Fig. 3C). These data indicate the
differential activation of Dyrk1 in response to mitogenic and
neurogenic growth factor. In particular, Dyrk1 activation may
contribute to neuronal differentiation by neurogenic bFGF in
the H19-7 cells.
Dyrk1 Directly Phosphorylates CREB in Response to bFGF—
Next we investigated whether active Dyrk1 could phosphoryl-
ate CREB. The H19-7 cell lysates obtained after bFGF treat-
ment were immunoprecipitated using anti-Dyrk1 antibodies,
and immunocomplex kinase assays were performed using bac-
terially expressed GST fusion protein with either wild type
CREB or S133A mutant CREB as a substrate. Phosphorylated
substrates were visualized by autoradiography. As shown in
Fig. 4, CREB phosphorylation was remarkably induced by
bFGF. Furthermore, transient transfection of kinase-deficient
Dyrk1 significantly diminished the bFGF-induced CREB
phoshorylation, whereas overexpression, in a similar way, of
wild type Dyrk1 proteins caused a remarkable induction of
CREB phosphorylation compared with the control cells. When
GST-CREB S133A, encoding CREB mutant, in which Ser-133
residue was substituted to Ala-133, was used as a substrate,
there was no significant phosphorylation of CREB (Fig. 4). In
addition, the effect of kinase-inactive Dyrk1 on the CREB phos-
phorylation was examined in H19-7 cells (Fig. 5). Consistent
with the previous finding that phospho-CREB selectively binds
to active Dyrk1, the addition of bFGF induced a marked CREB
phosphorylation. Furthermore, the overexpression of domi-
nant-negative Dyrk1 in a transient manner remarkably atten-
uated the CREB phosphorylation upon the stimulation with
bFGF compared with the control cells (Fig. 5). These data
suggest that Dyrk1 directly phosphorylates the Ser-133 residue
of transcription factor CREB during neuronal differentiation in
H19-7 cells.
Effect of Dyrk1 Activation on the CRE-dependent Gene Tran-
scription during Neuronal Differentiation—To assess whether
Dyrk1 exerts its stimulatory effect on CRE-mediated gene
transcription as well as on CREB activation, the gene expres-
sion of CRE-containing TK promoter-reporter construct was
assayed in response to bFGF (Fig. 6). Treatment of H19-7 cells
with bFGF resulted in the increase of CRE-mediated gene
transcription in a time-dependent manner, and it reached a
plateau after 4 h (12). To test the role of Dyrk1 activation on
CRE-mediated gene transcription, the cells were transfected
transiently with pCRE-TK-Luc reporter plasmid plus an ex-
pression vector encoding kinase-inactive Dyrk1 mutants
(pSVL-HA-Dyrk1A/K188R). Whereas the addition of bFGF led
to an increase of CRE-mediated reporter luciferase activity, the
expression of kinase-deficient Dyrk1 proteins with the muta-
tion of critical Lys-188 residue significantly inhibited the acti-
vation of luciferase activity triggered by bFGF (Fig. 6). Taken
together, these findings implied that neurogenic bFGF causes
the activation of CRE-mediated gene transcription, possibly
through the activation of Dyrk1 and subsequent CREB phos-
phorylation in embryonic CNS hippocampal cells.
FIG. 3. Selective activation of Dyrk1 in response to neurogenic
bFGF, but not mitogenic EGF, in H19-7 cells. Where specified,
H19-7 cells were stimulated with either 50 ng/ml EGF or 10 ng/ml
bFGF for the indicated times. The Dyrk1 was immunoprecipitated from
cell lysates, and the Dyrk1-bound protein mixtures were blotted with
monoclonal anti-phosphotyrosine (pTyr) antibodies. The quantity of
immunoprecipitated Dyrk1 kinase was determined by Western blot
analysis using anti-Dyrk1 antibodies (lower panel). All expressed re-
sults are representative of two independent experiments. A, EGF at
33 °C; B, bFGF at 39 °C; C, EGF at 39 °C (top panel) and bFGF at 33 °C
(bottom panel). IP, immunoprecipitation; No T, no treatment.
FIG. 4. Dyrk1 directly phosphorylates CREB in response to
bFGF in H19-7 cells. Where indicated, H19-7 cells were transfected in
a transient manner with 5 g of expression plasmid encoding either
wild type or kinase-deficient Dyrk1. The cells were then stimulated
with 10 ng/ml bFGF for 1 h, and total cell lysates were prepared. In
vitro CREB kinase assays were performed using bacterially expressed
GST fusion protein with either wild type CREB (GST-CREB) or S133A
CREB mutant (GST-mCREB) as an exogenous substrate. Kinase reac-
tion products were resolved by 10% SDS-PAGE, and the levels of
phosphorylated CREB were visualized by autoradiography. All ex-
pressed results are representative of three independent experiments.
WT, wild type of Dyrk1; MT, mutant type of Dyrk1; No T, no treatment;
Cont, control.
FIG. 5. Effect of kinase-deficient Dyrk1 on bFGF-induced
CREB phosphorylation. Where indicated, H19-7 cells were treated
with vehicle or transiently transfected with 5 g of plasmid encoding
kinase-deficient Dyrk1. Then, the cells were either untreated (N) or
stimulated with 10 ng/ml of bFGF for 1 h under differentiating condi-
tion. Total cell lysates were resolved by SDS-PAGE and analyzed by
Western blot analysis using the antibodies against CREB, Dyrk1, or
phosphorylated CREB. N, no treatment; C, control; MT, kinase-inactive
Dyrk1.
Activation of Dyrk1 during Neuronal Differentiation39822
 at Y
O
N
SEI U
N
IV
ERSITY
 on A
ugust 5, 2014
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
Effect of Dyrk1 Activation on Neuronal Differentiation in
H19-7 Cells—The functional role of Dyrk1 activation during
neuronal differentiation in H19-7 cells was further examined.
After treatment with bFGF, most of the H19-7 cells displayed
neurite extension at 39 °C at which the large T-antigen is
inactive (Fig. 7A). The differentiated cells were shown to be
resistant to mitogenic stimulation by serum and to express
neuronal markers such as neurofilament and brain type II
sodium channel (9, 16). The capability of the H19-7 cells to
differentiate in response to bFGF is similar to the response of
primary hippocampal cells during late embryogenesis, since
bFGFs act as a differentiating factor in certain CNS regions,
such as the hippocampus, to express bFGF receptor (33). After
a plasmid encoding either wild type or dominant-negative
Dyrk1 was transfected into the cells, the formation of neurite
outgrowth was subsequently analyzed. As shown in Fig. 7A,
the vehicle-transfected control cells displayed a similar per-
centage of differentiated cells (68%) in two separate transfec-
tion experiments. However, cells in the mutant Dyrk1-trans-
fected population exhibited only 26% differentiated cells (Fig.
7B). Interestingly, transient transfection of wild type Dyrk1
had no apparent effect on the neuronal differentiation in H19-7
cells (Fig. 7A). These results suggest that Dyrk activation is
likely to play an important role in the differentiation of neuro-
nal H19-7 cells.
DISCUSSION
The participation of Dyrk1 or other Dyrk-related kinases in
any particular signal transduction pathway has not been elu-
cidated so far. The selective recognition of the correct substrate
by protein kinase is an important biochemical mechanism that
underlies the specificity of cellular responses to various stimuli
(13). It is therefore important to determine the nature of Dyrk
substrate to understand its function in the regulation of cellu-
lar responses. Previously, Dyrk was shown to be required for
the proliferation of distinct neuronal cell types during postem-
bryonic neurogenesis in Drosophila (4). Mutant flies with a
reduced Dyrk1 expression have a reduced number of neurons
in distinct areas of the adult brain and exhibit specific behav-
ioral defects (4). In the present study we examined the cellular
Dyrk1 substrate and its functional role during neuronal differ-
entiation in hippocampal H19-7 cells. We have shown that
Dyrk1 is activated by neurogenic bFGF but not by mitogenic
EGF and that active Dyrk1 stimulates CREB phosphorylation
and subsequent CRE-mediated gene transcription. Our data
strongly suggest that Dyrk1 may play an important role during
neurogenic factor-induced differentiation in CNS neuronal
cells. Such a role was further supported by the finding that the
expression of kinase-deficient Dyrk1 in a transient manner
remarkably attenuates the formation of differentiated cells.
We have shown that the kinase-inactive Dyrk mutant could
block bFGF-induced phosphorylation of CREB (Fig. 5). Since
this mutant does not bind to CREB (Fig. 1), the effect in Fig. 5
might not be due to the competition between endogenous and
kinase-deficient Dyrk1 for CREB. Rather, it shows that if the
kinase-inactive mutant is working specifically, then it must act
by binding to the site that normally activates Dyrk1 and com-
peting with endogenous Dyrk1 there. Since there could be other
effectors that might also be activated at this site, such as
non-Dyrk1 proteins, then the kinase-minus Dyrk mutant
might block more than Dyrk1-mediated effects.
The Dyrk1 protein contains several striking structural fea-
tures, such as a bipartite nuclear localization signal, a PEST
region, repetitively present 17-serine/threonine residues, and
an activation loop (YQY motif) between subdomain VII and
VIII (14). Dyrk1 is localized to the cell nucleus (17), hence
gaining the potential to control the expression of other genes. A
green fluorescent protein-Dyrk1A fusion protein was found in
FIG. 6. Effect on bFGF-induced activation of Dyrk1 on CRE-
mediated gene transcription in H19-7 cells. Where indicated, 1 g
of DNA of pCRE-TK-Luciferase (CRE) reporter plasmid was transiently
transfected into H19-7 cells alone or along with 1 g of kinase-inactive
Dyrk1 K188R vector (MT). The cells were then untreated (C) or stim-
ulated with 10 ng/ml of bFGF (F) for 4 h, and the luciferase activity of
reporter plasmid was measured as described under “Experimental Pro-
cedures.” In every transfection experiment, the CRE-lacking TK pro-
moter construct, pTK-Luc (TK), was used as a negative control. Data
are plotted as the percent of maximum luciferase activity and represent
the mean plus range of samples from three independent experiments in
triplicate.
FIG. 7. Effect of Dyrk1 activation on bFGF-induced neuronal
differentiation. Where indicated, H19-7 cells were mock-transfected
(Vehicle) or transiently transfected with 5 g of either pSVL-HA-
Dyrk1A vector to express wild type Dyrk1 kinase (WT) or pSVL-HA-
Dyrk1A to express K188R Dyrk1 mutant (MT or mDyrk). The cells were
then either untreated or stimulated with 10 ng/ml bFGF (FGF) under
differentiation condition for 48 h, and the change of cell morphology was
observed by optical microscope (A). The differentiated cell percentages
were the ratios relative to the total cell numbers (B). The results
represent the mean plus the range of data from two independent ex-
periments in triplicates.
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the nucleus of transfected COS-7 or HEK293 cells (6, 17).
Furthermore, this kinase has been shown to be a dual specific-
ity protein kinase regulated by tyrosine phosphorylation in the
activation loop (14). This suggests that Dyrk1 might be a com-
ponent of a signaling pathway regulating nuclear events, but
exactly how Dyrk1 is involved in this mechanism has not been
elucidated so far. The present study, showing as it does that
Dyrk1 is activated by bFGF and could activate CREB and
subsequent CRE-mediated gene transcription, strongly sup-
ports the idea that Dyrk1 controls the expression of a certain
gene(s). It is possible that gene dosage for such a protein could
alter the expression of downstream genes and contribute to the
welter of phenotypic effects seen in DS (17).
We also found that bFGF does not affect the expression of
Dyrk1 and that significant levels of Dyrk1 continue to be con-
stitutively expressed in H19-7 cells. This is in good accordance
with previous reports that Dyrk1 is expressed strongly in the
brain from embryonic rat (18) and ubiquitously but most abun-
dantly in CNS regions of 17-day mouse embryo, such as in the
cerebral cortex, cerebellum, and the hippocampus (19, 20).
Neuronal activity plays a critical role in many forms of
synaptic plasticity such as learning and memory (21). Studies
on the formation of long term memory indicate that the induc-
tion of immediate early genes is often associated with memory
storage (22, 23). The immediate early gene products are
thought to activate late effector genes, which alter the struc-
tural and functional properties of nerve cells. Although the
molecular mechanism by which neuronal activity is coupled to
the alteration in gene expression is poorly understood, CREB
phosphorylation appears to be important in mediating the ex-
pression of several immediate early genes (24, 25). Moreover,
CREB has been implicated in the formation of long term mem-
ory. CREB supports memory in various organisms that perform
different behavioral tasks, from simple reflexes in mollusks to
complex emotional behaviors in mammals. For example, block-
ade of CREB activation by injection of CRE-containing oligo-
nucleotides has been found to impede long term facilitation, a
correlate of memory in the marine mollusk, Aplysia californica
(26). Knock-out mice with a deletion in the CREB gene and
Drosophila melanogaster expressing a repressor form of CREB
show deficits in long term memory without any effect on short
term memory (27, 28, 32).
The CNS limbic system, including the hippocampus, plays a
critical role in the processes of emotional behavior, memory,
integration of homeostatic responses, sexual behavior, and mo-
tivation. The transgenic mice overexpressing Dyrk1 in the fore-
brain, including the hippocampus, show significant defects in
learning and memory as well as long term potentiation (29, 30).
In addition, functional magnetic resonance imaging indicates a
lower level of metabolic activity in the hippocampus of these
mice (29). Underlying these changes are anatomical deficits in
the expression of hippocampal synaptic and axonal markers.
Furthermore, with progressing age, transgenic mice show a
significant reduction in hippocampal volume and a concomitant
enlargement in ventricular size, suggesting that the overex-
pression of Dyrk may affect postnatal hippocampal development.
Down’s syndrome is a developmental disorder. Individuals
with DS have a higher incidence of complicated medical prob-
lems (31). For example, children with DS are at increased risk
for congenital heart defects and have increased susceptibility to
infection, respiratory problems, obstructed digestive tracts,
and childhood leukemia. Adults with DS are at increased risk
for Alzheimer’s disease. Most people with DS have some level of
mental retardation. The secondary messenger cAMP regulates
a striking number of physiological processes, including inter-
mediary metabolism, cellular proliferation, and neuronal sig-
naling, by altering the basic pattern of gene expression via a
conserved CRE motif. In addition, CREB phosphorylation ap-
pears to be important in mediating the expression of various
kinds of genes and in the formation of long term memory, as
described previously. Based on the findings presented here that
Dyrk1 activates CREB during neuronal differentiation in CNS
hippocampal cells, further analysis of the upstream signaling
pathways activated by various neurogenic growth factors may
give deeper insights into the mechanism of neuronal differen-
tiation mediated by Dyrk1 activation.
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